Loading...
•
Dec 31, 2023
DexCom Q4 2023 Earnings Report
Dexcom's revenue grew, driven by volume and new customer additions, with significant increases in operating and net income.
Key Takeaways
Dexcom reported a strong fourth quarter in 2023, with revenue increasing by 27% year-over-year to $1.03 billion. GAAP operating income increased significantly, and net income saw a substantial rise. The company also provided annual guidance for 2024.
Revenue grew 27% year-over-year to $1.03 billion.
U.S. and International revenue both grew by 27%.
GAAP operating income increased by 560 basis points compared to Q4 2022.
Submitted Stelo, Dexcom’s new glucose sensor for people with type 2 diabetes who do not use insulin, to the FDA for review.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company is reiterating fiscal year 2024 guidance for Revenue, Non-GAAP Gross Profit Margin and Non-GAAP Operating Margin, and establishing Adjusted EBITDA Margin guidance.
Positive Outlook
- Revenue of approximately $4.15 - 4.35 billion (16 - 21% organic growth3)
- Non-GAAP Gross Profit Margin of approximately 63 - 64%
- Non-GAAP Operating Margin of approximately 20%
- Adjusted EBITDA Margin of approximately 29%
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...